Evaluation of innervation of the mitral valves and the effects of myxomatous degeneration in dogs
- PMID: 20113227
- DOI: 10.2460/ajvr.71.2.194
Evaluation of innervation of the mitral valves and the effects of myxomatous degeneration in dogs
Abstract
Objective: To map aspects of the innervation of the mitral valve complex and determine any association with the development or progression of myxomatous mitral valve disease (MMVD) in dogs.
Sample population: Septal mitral valve leaflets from 11 dogs aged 6 months to > 10 years.
Procedures: Expression of protein gene product 9.5 (general neuronal marker), tyrosine hydroxylase (adrenergic innervation marker), vasoactive intestinal peptide (parasympathetic innervation marker), and calcitonin gene-related peptide (sensory innervation marker) was assessed by use of a standard immunohistochemical technique. Innervation was assessed qualitatively and semiquantitatively. Differences between valvular zones and between groups were analyzed statistically.
Results: MMVD was present in leaflets of all dogs > or = 5 years of age. Innervation was confirmed in all leaflets but was markedly reduced in leaflets of dogs > 10 years of age. Innervation was most dense at the base of valves and mainly associated with the epimysial, perimysial, and endomysial layers of the muscle and blood vessels within the valve. Innervation was reduced within the middle zone of the valve and lacking at the free edge. Innervation was not identified at the tip of the leaflet, the free edge, or the chordae. Nerve fibers were mostly sympathetic, with the remainder being parasympathetic or sensory. Existence of MMVD did not alter the pattern or density of innervation.
Conclusions and clinical relevance: Mitral valve leaflets in the study dogs were innervated, with most of the nerve fibers associated with the myocardium in the valve base. Development of MMVD appeared to precede the reduction of innervation associated with advancing age.
Similar articles
-
Distribution of myofibroblasts, smooth muscle-like cells, macrophages, and mast cells in mitral valve leaflets of dogs with myxomatous mitral valve disease.Am J Vet Res. 2008 Jun;69(6):763-9. doi: 10.2460/ajvr.69.6.763. Am J Vet Res. 2008. PMID: 18518656
-
Structural and cellular changes in canine myxomatous mitral valve disease: an image analysis study.J Heart Valve Dis. 2010 Jan;19(1):60-70. J Heart Valve Dis. 2010. PMID: 20329491
-
Pathology of myxomatous mitral valve disease in the dog.J Vet Cardiol. 2012 Mar;14(1):103-26. doi: 10.1016/j.jvc.2012.02.001. Epub 2012 Mar 3. J Vet Cardiol. 2012. PMID: 22386587 Review.
-
Pathology, protein expression and signaling in myxomatous mitral valve degeneration: comparison of dogs and humans.J Vet Cardiol. 2012 Mar;14(1):59-71. doi: 10.1016/j.jvc.2012.01.005. Epub 2012 Feb 24. J Vet Cardiol. 2012. PMID: 22364722 Review.
-
Evaluation of plasma and urinary levels of 6-keto-prostaglandin F1alpha as a marker for asymptomatic myxomatous mitral valve disease in dogs.Vet J. 2010 May;184(2):241-6. doi: 10.1016/j.tvjl.2009.02.012. Epub 2009 Mar 25. Vet J. 2010. PMID: 19324577
Cited by
-
The Role of Transforming Growth Factor-β Signaling in Myxomatous Mitral Valve Degeneration.Front Cardiovasc Med. 2022 May 17;9:872288. doi: 10.3389/fcvm.2022.872288. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35656405 Free PMC article.
-
Comparative transcriptomic profiling of myxomatous mitral valve disease in the cavalier King Charles spaniel.BMC Vet Res. 2020 Sep 23;16(1):350. doi: 10.1186/s12917-020-02542-w. BMC Vet Res. 2020. PMID: 32967675 Free PMC article.
-
Differentiating the aging of the mitral valve from human and canine myxomatous degeneration.J Vet Cardiol. 2012 Mar;14(1):31-45. doi: 10.1016/j.jvc.2011.11.003. Epub 2012 Feb 24. J Vet Cardiol. 2012. PMID: 22364720 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources